{{knowledge objective
|Identifiant=OIC-078-09-A
|Item_parent=Addiction to cannabis, cocaine, amphetamines, opiates, synthetic drugs. (see item 322)
|Item_parent_short=Addiction to cannabis, cocaine, amphetamines, opiates, synthetic drugs. (see item 322)
|Rank=A
|Title=Know how to diagnose a withdrawal syndrome.
|Description=Incidence, chronology, semiology
|Rubric=Positive diagnosis
|Contributors=
|Order=9}}
'''Cannabis''':

- Appears 24 to 72 hours after stopping heavy, regular consumption (10 to 40% of users)

- Maximum in the first week

- Duration: 1 to 3 weeks

- Symptoms: irritability, aggression, anxiety, impatience, inability to stay put, sadness, anorexia and/or weight loss, sleep disorders (lasting up to a month), physical signs (abdominal pain, vomiting, tremors, sweating, chills, fever, headaches).

'''Cocaine''':

'''Clinical picture of depressive appearance''' with :

- dysphoric mood, asthenia, hypersomnia, increased appetite, psychomotor slowing, agitation

- appear a few hours after stopping cocaine and can last for several weeks.

'''Amphetamines''' :

- Occurs within a few days of stopping and can last several weeks,

- especially if consumed intravenously or by inhalation

- Depressive symptoms

'''Opiates/opioids''' :

- Intensity of symptoms dependent on whether the opioid used is a strong or weak agonist and on the dose consumed

- The onset and duration of the withdrawal syndrome depend on the half-life of the opiate usually ingested.

o Heroin: withdrawal symptoms 6 to 12 hours after the last dose, lasting 3 to 7 days.

o Methadone: withdrawal symptoms after 2 to 4 days, lasting up to 3 weeks

- Symptomatology :

o Flu-like syndrome with diffuse, sometimes intense pain, myalgia or even muscle contractures and digestive symptoms (abdominal cramps, diarrhoea, vomiting).

o Neurovegetative signs: yawning, lacrimation, rhinorrhea, mydriasis, tachycardia, hypertension

o Psychiatric and addictive signs: anxiety, irritability, aggressiveness, craving, insomnia, agitation

o Biological signs: haemoconcentration, hyperleukocytosis, hyperglycaemia

'''New synthetic products''' :

- Withdrawal syndrome (e.g. MDPV and mephedrone): sad mood, anxiety, sleep disorders, anhedonia, anergy, asthenia, concentration problems, palpitations and headaches.

.     For synthetic cannabinoids: withdrawal symptoms such as inner tension, nightmares, sweating, headaches, nausea and tremors.